secwatch.observer — SEC 8-K summary
======================================

Issuer:     Microbot Medical Inc. (MBOT)
CIK:        0000883975
Form:       8-K
Filed at:   2026-07-07T12:30:39+00:00
Accession:  0001493152-26-032260
Event type: other_material
Sentiment:  positive
Materiality: 0.80
Item codes: 7.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Microbot Medical reports >100% revenue and customer growth for Q2 2026 vs Q1 2026
--------------------------------------------------------------------------------

- Revenue and new customers grew more than 100% in Q2 2026 compared to Q1 2026.
- LIBERTY System adopted by leading health systems in Massachusetts, North Carolina, Michigan, and Pennsylvania.
- Entered agreement with Lovell Government Services to serve federal healthcare systems including VHA, MHS, IHS.
- Received marketing clearance for LIBERTY system from Israeli Ministry of Health, first international approval.
- Plans to expand U.S. sales territories from 8 to 12 and enter international markets by end of 2026.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/883975/000149315226032260/0001493152-26-032260-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/883975/000149315226032260/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-032260

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer